The company plans to add assays for Group B Streptococcus, Clostridium difficile, and norovirus in 2016 to complement its existing meningitis test.
The instrument is designed exclusively for use with the company's portfolio of molecular infectious disease assays, including its recently launched HG Meningococcus
The test is the first in the Dublin, Ireland-based firm's pipeline of infectious disease assays that use loop-mediated isothermal amplification.
The FilmArray ME Panel is the first nucleic acid amplification test to detect multiple pathogens from a single cerebrospinal fluid sample.
The UCSF Center for Next-Gen Precision Medicine Diagnostics will use NGS to develop technology to diagnose meningitis and encephalitis.
A French team sequenced and compared Streptococcus agalactiae isolates from 19 mothers and their infected infants.
The partners will focus on sequencing and analyzing bacteria and viruses that cause a number of diseases as well as those that make up human microbiomes.
FilmArray ME tests cerebrospinal fluid for the most common bacteria, viruses, and fungi responsible for community-acquired meningitis or encephalitis.
HiberGene hopes to launch its assays, based on loop-mediated isothermal amplification, in the EU in the third quarter of this year.
After receiving ISO certification and publishing studies on its technology in 2014, the Australian MDx firm is targeting a launch of its meningitis test in 2015.
At a meeting this week, researchers and others discussed the regulatory oversight needed for germline genome editing.
The US Food and Drug Administration has asked questions about Myriad Genetics' GeneSight test, according to Bloomberg.
Researchers report that neutrophil extracellular traps appear to binds gallstones together, according to New Scientist.
In Science this week: approach to infer genotype-by-environment interaction from genetic variants associated with phenotypic variability, and more.